Cargando…

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice

Background: Farnesoid X receptor (FXR) is a key metabolic target of bile acids (BAs) and is also a target for drugs against several liver diseases. However, the contribution of FXR in the pathogenesis of cholestasis is still not fully understood. The purpose of this study is to provide a comprehensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shizhang, He, Tingting, Zhao, Xu, Jing, Manyi, Li, Haotian, Chen, Lisheng, Zheng, Ruimao, Zhao, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239812/ https://www.ncbi.nlm.nih.gov/pubmed/37284301 http://dx.doi.org/10.3389/fphar.2023.1197847

Ejemplares similares

Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis
por: Xie, Shuying, et al.
Publicado: (2023)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Chen, Lisheng, et al.
Publicado: (2021)

Metabolomics Profiles Associated with the Treatment of Zuojin Pill on Patients with Chronic Nonatrophic Gastritis
por: Ma, Xiao, et al.
Publicado: (2022)

Paeoniflorin Protects against ANIT-Induced Cholestatic Liver Injury in Rats via the Activation of SIRT1-FXR Signaling Pathway
por: Chen, Lisheng, et al.
Publicado: (2021)

Emodin Rescues Intrahepatic Cholestasis via Stimulating FXR/BSEP Pathway in Promoting the Canalicular Export of Accumulated Bile
por: Xiong, Xiao-Li, et al.
Publicado: (2019)

Polygoni Multiflori Radix interferes with bile acid metabolism homeostasis by inhibiting Fxr transcription, leading to cholestasis
por: Dai, Yihang, et al.
Publicado: (2023)

Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
por: Xi, Lili, et al.
Publicado: (2023)

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
por: Li, Yun, et al.
Publicado: (2021)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Alterations of the Human Gut Microbiota in Intrahepatic Cholestasis of Pregnancy
por: Zhan, Qitao, et al.
Publicado: (2021)

Rutaecarpine Ameliorates Ethanol-Induced Gastric Mucosal Injury in Mice by Modulating Genes Related to Inflammation, Oxidative Stress and Apoptosis
por: Ren, Sichen, et al.
Publicado: (2020)

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver–Gut Axis
por: Liu, Linlin, et al.
Publicado: (2020)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021)

Clinical Efficacy and Safety of Shashen Maidong Decoction in the Treatment of Pediatric Mycoplasma Pneumonia: A Systematic Review and Meta-Analysis
por: Wang, Jiawei, et al.
Publicado: (2021)

Treatment of Chronic Gastritis with Traditional Chinese Medicine: Pharmacological Activities and Mechanisms
por: Chen, Lisheng, et al.
Publicado: (2023)

Mechanism of crocin I on ANIT-induced intrahepatic cholestasis by combined metabolomics and transcriptomics
por: Song, Dandan, et al.
Publicado: (2023)

Berberine Attenuates Chronic Atrophic Gastritis Induced by MNNG and Its Potential Mechanism
por: Tong, Yuling, et al.
Publicado: (2021)

Disordered Gut Microbiota in Colorectal Tumor-Bearing Mice Altered Serum Metabolome Related to Fufangchangtai
por: Cai, Mengmeng, et al.
Publicado: (2022)

Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
por: Jiang, Yinxiao, et al.
Publicado: (2021)

Alterations in gut microbiota and metabolite profiles in patients with infantile cholestasis
por: Jin, Meng, et al.
Publicado: (2023)

Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling
por: Xiao, Yongtao, et al.
Publicado: (2018)

Metabolomics Profiles Reveal the Efficacy of Wuzhuyu Decoction on Patients with Chronic Non-Atrophic Gastritis
por: Hu, Qichao, et al.
Publicado: (2023)

Celastrol-regulated gut microbiota and bile acid metabolism alleviate hepatocellular carcinoma proliferation by regulating the interaction between FXR and RXRα in vivo and in vitro
por: Zeng, Dequan, et al.
Publicado: (2023)

Response of gut microbiota to serum metabolome changes in intrahepatic cholestasis of pregnant patients
por: Li, Guo-Hua, et al.
Publicado: (2020)

Untargeted Metabolomics Reveals Dose-Response Characteristics for Effect of Rhubarb in a Rat Model of Cholestasis
por: Zhang, Cong-En, et al.
Publicado: (2016)

Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery
por: Wei, Shizhang, et al.
Publicado: (2020)

Correction: Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling
por: Xiao, Yongtao, et al.
Publicado: (2022)

Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders
por: Appelman, Monique D., et al.
Publicado: (2021)

Clinical Efficacy and Safety of Qishen Yiqi Dropping Pill Combined with Conventional Western Medicine in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Lisheng, et al.
Publicado: (2021)

Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics
por: Xu, Hui, et al.
Publicado: (2022)

Metabolomics Coupled with Multivariate Data and Pathway Analysis on Potential Biomarkers in Cholestasis and Intervention Effect of Paeonia lactiflora Pall.
por: Ma, Xiao, et al.
Publicado: (2016)

Integrated Lipidomics and Metabolomics Study of Four Chemically Induced Mouse Models of Acute Intrahepatic Cholestasis
por: Li, Weiwei, et al.
Publicado: (2022)

Combining fecal microbiome and metabolomics to reveal the disturbance of gut microbiota in liver injury and the therapeutic mechanism of shaoyao gancao decoction
por: Li, Jingwei, et al.
Publicado: (2022)

Cholestasis: exploring the triangular relationship of gut microbiota-bile acid-cholestasis and the potential probiotic strategies
por: Yu, Leilei, et al.
Publicado: (2023)

Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis
por: Wang, Yizhong, et al.
Publicado: (2019)

BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination
por: Jung, Hyunkyung, et al.
Publicado: (2020)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

Anti-Inflammatory Effect of a TCM Formula Li-Ru-Kang in Rats With Hyperplasia of Mammary Gland and the Underlying Biological Mechanisms
por: Wang, Yingying, et al.
Publicado: (2018)

Obeticholic Acid Induces Hepatoxicity Via FXR in the NAFLD Mice
por: Lin, Chuangzhen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sodi8q9ujpi00ua88fhno4vp7l